Canada markets closed

Dechra Pharmaceuticals PLC (DPH.L)

LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
3,552.00+62.00 (+1.78%)
At close: 04:45PM BST
Show:
Annual

Income Statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
2021-06-30
2020-06-30
2019-06-30
2018-06-30
Total Revenue
640,600
608,000
515,100
481,800
407,100
Cost of Revenue
276,700
262,100
223,500
208,700
184,700
Gross Profit
363,900
345,900
291,600
273,100
222,400
Operating Expenses
Research Development
30,800
32,400
28,400
25,100
18,300
Selling General and Administrative
158,300
151,300
134,900
125,700
110,000
Total Operating Expenses
264,300
258,900
232,900
227,600
182,400
Operating Income or Loss
99,600
87,000
58,700
45,500
40,000
Interest Expense
9,900
9,800
11,500
10,500
6,900
Income Before Tax
92,000
74,000
40,900
27,800
28,900
Income Tax Expense
19,100
18,500
7,000
-3,100
-7,200
Income from Continuing Operations
72,900
55,500
33,900
30,900
36,100
Net Income
72,900
55,500
33,900
30,900
36,100
Net Income available to common shareholders
72,900
55,500
33,900
30,900
36,100
Basic EPS
-
0.51
0.33
0.30
0.37
Diluted EPS
-
0.51
0.33
0.30
0.37
Basic Average Shares
-
108,120
103,133
102,505
96,942
Diluted Average Shares
-
108,751
103,482
102,762
97,451
EBITDA
-
159,000
122,000
115,100
89,900